Supplementary
. Live cell colocalization study of the HRas-cRaf RBD interaction. (a) The C-terminal CAAX motif of HRas is known to undergo series of posttranslational modifications including farnesylation 35 . This post-translational modification is recognized as the indispensable event to translocate HRas to the plasma membrane 36 . We deleted the CAAX motif, which resulted in diffusive distribution of HRas in the cytoplasm.
To induce on-demand translocation of HRas to the plasma membrane, we used FKBP-FRB heterodimerization that can be triggered by rapamycin 13 . The FRB domain was fused to Lyn tyrosine kinase. Since the N-terminal 11 amino acids of Lyn contain sites for myristoylation and palmitoylation, Lyn-FRB is stably anchored to the plasma membrane.
The FKBP domain was fused to the CAAX-deleted HRas. When the rapamycin was added, the FKBP-conjugated HRas was captured by the Lyn protein through FKBP-FRB heterodimerization, which effectively translocated HRas to the plasma membrane. The protein-protein interaction between HRas and Ras binding domain of raf1 (cRaf RBD ) was assessed by seeing whether cRaf RBD was also translocated to the plasma membrane. (b) In order to analyze co-localization of HRas and cRaf RBD , we measured fluorescence intensity of a specific region of interest (ROI) inside cells. We designated ROI 1 and ROI 2, in which fluorescence intensity changes in the plasma membrane and cytoplasm were recorded, respectively. When constitutively active HRas (Q61L) was translocated to the plasma membrane, the fluorescence signal of HRas in ROI 1 increased by a factor of seven during 10 min imaging, which was accompanied by a decrease in fluorescence signal in ROI 2 to one sixth of the initial value. It is noted that the fluorescence signal of cRaf RBD showed concurrent increase in ROI 1 by a factor of six. When dominant negative HRas (S17N) was used for the same experiment, on the other hand, we observed similar level of HRas translocation to the plasma membrane. However, the cRaf RBD fluorescence levels in both ROI 1 and 2 largely remained unchanged, indicating a minimal interaction between cRaf RBD and dominant negative HRas. the dominant negative mutation (S17N), meaning that 80% of the spots showed no binding events. We noted that even with the active mutation, the co-localization percentage was 70% and didn't reach 100%. These 30% spots seemed to be fluorescence junk. (b) We analyzed single-molecule kinetics from the identified co-localized spots. When we assessed the binding kinetics from the colocalized spots, the kinetic rates of k bind and k diss were measured to be 0. Ras-Raf complex because the histograms show relatively broad distributions around the main peak. However, in every histogram, there is no other appreciable peak that could be attributed to a distinct state. Moreover, both the dwell time kinetics for τ on and τ off can be fitted using single exponential functions ( Fig. 1 and 2) . Thus, we have presumed one welldefined conformation state for the final Ras-Raf complex throughout our analysis. 

, where (i,j) is the position of the pixel under consideration, (x k , y k ) is the position of the kth PSF and σ is the standard deviation of the PSF. A is the peak intensity of the PSF that has been adjusted to match the experimental data from Figs. 1 and 2 (A=158.7 used). To simulate shot noise of imaging, a Poisson noise was added for each pixel. It should be noted that in this computer-generated movie, the fluorescence signals only come from the eGFP-cRaf RBD proteins in the final HRas-cRaf RBD complex, without any contribution from freely diffusing cRaf RBD s or encounter complexes.
The movies were generated as the total HRas numbers were increased up to 76,000, which corresponded to on average 20 HRas per μm 2 . In analyzing the movies, we used the same method described in Supplementary Figure S5 This means that even when the total immobilization number of HRas is increased, the kinetic constant largely stays at the same value up to a certain point. However, if the total immobilization number is increased beyond a certain threshold, more than one active HRas molecules begin to be included in some of ROIs (upper right). These additional HRas molecules create additional fluorescence spikes (lower right, red spikes), which make τ off,apparent smaller than the genuine τ off,single HRas . As a result, the measured kinetic rate of k bind,apparent is expected show a biphasic behavior as a function of total HRas immobilization number. The k bind,apparent is initially maintained at a constant of k bind,single HRas , but begins to increase beyond the threshold. We note that this threshold for k bind,apparent corresponds to a specific surface density of active baits, which is independent of detailed molecular nature of bait proteins. Thus, comparing the thresholds can be directly used to assess the active portion of bait proteins on surface. Figure S15 . k diss observed for native signaling Ras. Unlike k bind that shows inflation past the thresholds (Fig. 3l and Fig. 4c ), k diss is largely constant for every HRas and KRas sample we studied. We note that τ on values are in the range of hundreds of ms, showing that the rapid turnover in Figs. 1 and 2 is also observed for the native Ras pulled down from both tumor and control tissues. was too weak at 0.5 mg/mL and lower, we selected the cases of 1 mg/mL lysate to calculate the Ras concentrations from the standard curve of a. The KRas concentrations are 3.2 nM for MDA-MB-231 and 9.7 nM for MCF-7 in 1 mg/mL cell extracts, respectively. These values are little bit lower than those from our single-molecule western analysis from Fig. 4 (5.5 and 17.3 nM), which seems to be due to loss of proteins during transfer to PVDF membrane prior to immunoblotting. (c) We however note that the Ras-concentration ratio of MCF-7 to MDA-MB-231 is 3.03 (9.7 nM/3.2 nM), which is very close to the value of 3.14 (17.3 nM/5.5 nM) estimated by the single-molecule western analysis. This reconfirms our important finding that the mutant KRas in MDA-MB-231 cells has a smaller concentration than the wild-type KRas in MCF-7 cells.
